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Freezing of gait is a warning sign of Parkinson’s disease. One could distinguish oﬀ-freezing, which is associated with dopaminergic
therapy and to its titration, and it is clinically related to wearing-oﬀ phenomenon. Diﬀerently, the on-freezing phenomenon seems
to be related to a neural disruption of the frontal-parietal-basal ganglia-pontine projections; clinically, it does not respond to
therapy modiﬁcations or to diﬀerent drug titration. In a group of patients with on-freezing, we have detected an alteration of
focusing attention, an impairment of set-shifting, in addition to poor abstract reasoning and a reduction of planning. These
aspects have been even more evident, when compared with the results obtained by a group of PD patients, without freezing.
1.Introduction
Freezing of gait (FOG) refers to transient episodes, usually
lasting seconds, in which a patient is unable to initiate or
continue locomotion, especially while turning, in stressful
time-constrained situations and upon entrance into and
through conﬁned spaces such as doorways occurring on a
background of relatively good ability to move [1–3]a n d
is best described by patients as “feet get glued to the
ground.” FOG typically appears when a patient is forced
to change his normal, automatic gait pattern or speed (at
tight quarters, reaching destination) or when responding to
stressful situations [4].
Freezing of gait is common in Parkinson’s disease (PD),
with increasing prevalence as the disease progresses [1, 2, 5–
7], but it has been commonly reported in pathologically
proven progressive supranuclear palsy (PSP) and vascular
parkinsonism [8, 9]. Although not present in all patients,
freezing is perhaps the most debilitating symptom of Parkin-
son’sdiseaseasitmayleadtofalls,adecreaseinqualityoflife,
and loss of independence. Nearly one third of Parkinson’s
disease patients experience some type of freezing episode
[1, 10].
To be precise, two types of freezing of gait have been
recognized in patients aﬀected by Parkinson’s disease, taking
L-Dopa.Themostcommonisan“oﬀ-”freezingofgait,which
can be improved with L-Dopa or dopaminergic treatment,
such as apomorphine [4, 11]. “Oﬀ-”freezing appears during
an “oﬀ” state, when the patient is generally bradykinetic and
rigid.
Incontrast,“on-”freezingischaracterizedbyaworsening
of symptoms as the dose of L-Dopa is increased and by a
general improvement as the dose is decreased or, better said,
modulated. Patients who experience “on-”FOG frequently
report that they walk better before the ﬁrst morning dose
of L-Dopa, or at their “oﬀ” state. On-freezing lasts for
short times: generally few seconds, at most several minutes.
The on-freezing of gait is related to abnormal execution
of complex motor tasks such as repetitive, simultaneous,
or sequential motor acts [12–14]. Recent evidence has
suggested other possible factors that may contribute. In
their more recent work, Giladi et al. [15] argue that FOG
must have a diﬀerent pathophysiology than typical motor
symptom, since other motor issues are positively inﬂuenced
by dopaminergic medication, while freezing remains unre-
sponsive.
Diﬀerent authors suggested that the primary underlying
abnormality might be related to the inability to deliver or
hold a preprogrammed, continuous, and complex motor
act, in response to an established and correct internal
plan of action [12, 13]. Increased stride-to-stride variability
has recently been identiﬁed before FOG (compared with
Parkinson’s disease patients without FOG) during a 20m2 Parkinson’s Disease
Table 1: (a) Speciﬁc scores of the two groups, (b) speciﬁc scores of the two groups.
(a)
Group A Group B Group A Group B
in on in oﬀ
Freezing when walking (UPDRS II) 2.7 ± 1.2 1.2 ± 0.4 2.9 ± 0.7 3.1 ± 0.3
Walking (UPDRS II) 2.4 ± 0.5 0.9 ± 0.7 2.5 ± 0.2 2.7 ± 0.1
Gait (UPDRS III) 2.5 ± 0.3 1.1 ± 0.9 2.6 ± 0.2 2.9 ± 0.4
(b)
Group A Group B Group A Group B
in on in oﬀ
Hohen and Yahr, Goetz et al. [14, 26]2 . 5 ± 0.1 2.2 ± 0.7 3.5 ± 1.1 3.9 ± 0.2
(UPDRS II) [27] 18.4 ± 0.5 17.9 ± 5.7 20.5 ± 1.2 23.7 ± 0.1
(UPDRS III) [27] 28.5 ± 1.3 29.1 ± 0.9 34.6 ± 1.5 37.9 ± 1.4
“stand up and go” walking task [16]; in this work, it has
beendemonstratedthattheabilitytoregulatestride-to-stride
timing during gait is severely impaired in FOG patients
compared with other individuals with Parkinson’s disease
[16]. Parkinson’s disease patients with FOG also display
altered timing and, speciﬁcally, premature muscle activation
andterminationpatternsbeforeafreezingepisode,leadingto
an abnormally long stance phase [17–19]. Perception may be
the most important alternate mechanisms to consider. While
perceptual inﬂuences associated with freezing are rarely
considered,Parkinson’sdiseasepatientsareprofoundlyinﬂu-
enced by awareness of their body (relative to environment)
[10, 16, 20, 21] and by space perception [22, 23]. Impaired
integration of vision with spatial memory altered recovery
mighthelpFOGpatientsinadaptingtoconﬁnedspaces[24].
Considering that the “on-FOG” is a complex phe-
nomenon,withanobscurepathogenesisandanevenobscur-
er clinical history [4, 25], we hypothesized that PD patients,
presenting the on-freezing, might be cognitively well diﬀer-
entiated from the other clinical subtypes of PD, without on-
FOG.
Therefore, several patients were chosen, presenting on-
freezing as an early manifestation of PD, and their cognitive
a n db e h a v i o r a ls c o r e so nd i ﬀerent speciﬁc tasks were com-
pared with those obtained by patients with PD, without on-
freezing, but manifesting oﬀ-freezing. The clinical and neu-
ropsychological followup was done in 12 months.
2. Method
2.1. Subjects. The study included 73 patients (40 men and 33
women) suﬀering from idiopathic PD [29]. Three patients
did not want to be tested and therefore did not participate
to the followup. All the other patients could be fully studied
(mean age 68.4 ± 7.12 years, range = 60–78 years; average
age at onset = 63.22 ± 3.12 years, range = 62–67 years). The
patientssuﬀeredforameanof3.56 ±2.75yearsfromPDand
had been treated with dopaminergic preparations (L-Dopa
and dopamine-agonists).
AllthepatientsfulﬁlledthecriteriaofidiopathicPD[29].
Group A enclosed 38 cases of PD, who presented on-
freezing,asreferredbycaregivers,andconﬁrmedbypersonal
trainers and by their neurologist (three patients of this group
refused to complete the study). On-freezing was veriﬁed
historically and by an actual gait assessment at on and at oﬀ
(see Table 1(a)). Group B was composed by 35 Parkinson’s
disease patients, without on-freezing (but with oﬀ-freezing).
P a t i e n t sw e r ee v a l u a t e di no ﬀ- and on-pharmacological
states (see Table 1(b)). All the patients responded to L-
Dopa. The mean L-Dopa equivalent dosage was 1215 ±
321.34mg/day. 43 patients received dopamine agonists dur-
ing their cure; only 27 began their therapy with dopamine-
agonists.
All the subjects were right handed (+22.34 ± 1.32)
according to the Briggs’ and Nebes’ handedness test [28].
Their average educational levels, represented by school years,
are of 11.34 ± 5.67 years.
Patients were divided into two homogenous groups,
matched for age and education levels. Patients have been
followed for one year. 33 patients of Group A and 29 patients
of Group B completed the followup.
Neuroimaging studies were assessed, including magnetic
resonance imaging (in 32 patients, 17 in group A and 15 in
group B) and CT scans (in all the patients). Neither signs of
normal pressure hydrocephalus, nor ischemic infarctions or
lacunar infarcts have been found.
The trial was conducted in accordance with the Dec-
laration of Helsinki and with the Ethics Guidelines of the
Institute.
2.2. Outcome Measures. The general cognitive proﬁle was
tested by this battery of tests: Stroop Test [30], considering as
subscores the time of execution and the number of mistakes,
Raven Standard Progressive Matrices [31], considering as
sub-scores the time of execution and the number of correct
answers, Digit span backwards and forwards [32], the oral
version of the Trail Making, part A [33] considering as sub-
scores the time of execution and the number of mistakes,
word ﬂuency, considering three minutes of phonological
task[32],Proverbs’InterpretationTest[34],Ten-PointClockParkinson’s Disease 3
Table 2: Synopsis of the baseline characteristics of the two groups.
Group A Group B
Age 68.31 ± 4.12 65.45 ± 1.23
Average age at onset 63.78 ± 1.56 63.01 ± 1.21
Illness duration 3.12 ± 1.12 3.87 ± 3.5
Mean L-Dopa
equivalent dosage
1212 ± 121.34
mg/day
1200 ± 621.45
mg/day
Handedness test [28] +23.10 ± 1.50 +20.50 ± 2.30
Average educational
levels (school years) 11.11 ± 3.45 years 13.11 ± 5.20 years
Test [35], verbal retrieval [36], and Clinical Insight [37]. The
patients underwent a Cornell evaluation for depression [38].
In particular, we employed the item: “anxiety” from the
Cornell’s scale, with a maximum score of 8, which indicate
a maximum degree of anxiety, as an adjunctive informative
parametric score, of mood.
All the patients have been tested (as far as neuropsy-
chological measures are concerned) in on-pharmacological
state; so far, all the patients should have the most convincing
performances; in fact, no oﬀ-freezing has been detected. On
the contrary, on-freezing, in group A, appears frequently
during the test.
2.3. Statistical Analyses. Statistical analyses were performed
using the Statistical Package for the Social Sciences (SPSS,
version 13.0). Within-group changes from baseline to 12
months were tested using the Wilcoxon Signed Ranks test,
due to the small number of patients enrolled. Between-
group comparisons of changes from baseline were tested
using the Wilcoxon two-sample test. This was done for
t h eo v e r a l ls c o r e sf o re a c he ﬃcacy variable. Spearman’s
rho correlation, 2-tailed analyses were performed among
digit span (forward and backward), phonological ﬂuency,
proverbs’ interpretation and clock execution, and between
clinical insight and depression scores. Results are presented
asmeanchangesfrombaselinewithstandarddeviations,and
P-values are presented where appropriate.
3. Results
A synopsis of the characteristics of the two groups has been
reported in Table 2. Table 3 reports the results obtained at
baseline by the two groups. Group A manifested transient
episodes, usually lasting seconds. During this kind of
episode, a patient is unable to initiate a sentence or talk as
he did before. At the end of the episode, usually after few
seconds, he starts again to talk and to express his opinions,
beginning from the point when he was interrupted. We
deﬁne these episodes as “freezing of thought or freezing of
speech.”
According to a Wilcoxon two-sample test, Group A (on-
FOG PD) had lower scores than Group B (PD patients) in
the digit span forward task (P<0.05); they made more
mistakes in the Trail Making test (P< 0.01), in Proverbs’
Interpretation task (P<0.01), in the Stroop Test (P<0.01)
(execution time and number of mistakes), and in the Ten-
PointClockTest(P<0.01).However,GroupAscoredhigher
than Group B in the phonological task (P<0.01). The two
groups did equally well in the digit span backward task, in
the Trail Making Test (considering time of execution), in the
RavenMatrices(timeandnumberofcorrectanswers),andin
the memory recall tasks. Group B scored as more depressed
than Group A on the Cornell’s Score (P<0.01), but patients
from Group B reported greater introspection in their clinical
situation (P<0.01) on the Cornell’s Score subitem. There
was no diﬀerence among the two groups, when considering
the anxiety scores (subitem of the Cornell’s Score).
Table 4 reports the results obtained at 12 months by
the two groups. Within-group changes from baseline to
12 months were tested using the Wilcoxon Signed Ranks
test; between-group comparisons of changes from baseline
were tested using the Wilcoxon two-sample test. Group A
(on-FOG PD) scored worse, over baseline according to a
Wilcoxon Signed Ranks test, in the digit span backward
(P<0.05), in Proverbs’ Interpretation Test (P<0.05)
and in the Stroop test (P<0.05) (time of execution and
number of mistakes). Group B (PD) scored worse over
baseline in the digit span backward test (P<0.05) and in
the Cornell’s Scale (P<0.01). Group B improved in the
Proverbs’ Interpretation Test (P<0.05). Group A scored
worse than Group B, according to a Wilcoxon two-sample
test, in the digit span forward task (P<0.05) and made
more mistakes in the Trail Making test (P< 0.01), in
Proverbs’ Interpretation task (P<0.01); they scored more
poorly in the Stroop Test (P<0.01) (execution time and
number of mistakes) and in the Ten-Point Clock Test (P<
0.01). Like at baseline, Group A scored better than Group
B in the phonological task (P<0.01). Group B reported
being more depressed than Group A, as demonstrated by the
Cornell’s Score (P<0.01), and continued to show greater
introspection in the clinical situation (P<0.01), on the
Clinical insight rating Scale (CIR). The anxiety score for
Group A was lower than that of group B (P<0.05).
Only Group A patients manifested freezing of thought,
freezing of speech, or both.
Spearman’s rank correlation analyses indicated that there
was a signiﬁcant correlation between the digit span scores
and the proverbs’ interpretation scores (r = 0.78, P<0.01;
r = 0.81, P<0.01, resp.) and between the digit span scores
and the Ten-Point Clock Test (r = 0.69, P<0.05; r = 0.72,
P<0.01, resp.); no correlation was found between digit span
scores and the phonological ﬂuency. A positive correlation
between CIR and Cornell’s Scale (r = 0.88, P<0.01) was
found.
4. Discussion
Freezingofgait(FOG),asstatedpreviously,isacomplication
of PD. Iansek et al. [39] suggested that FOG during walking
was possibly due to the presence of the “sequence eﬀect”
(gradual step to step reduction), in combination with an
overall reduced step length which, if small enough, would
eventually lead to freezing. That hypothesis was based on
the duality of basal ganglia function and malfunction in4 Parkinson’s Disease
Table 3: A comparison between the two groups, at baseline.
Items Group A Group B P
Phonological ﬂuency 23.12 ± 9.10 12.12 ± 2.11 P<0.01
Intrusion mistakes 8.90 ± 2.34 2.34 ± 0.12 P<0.01
Digit span forward 3.34 ± 0.50 4.75 ± 1.12 P<0.05
Digit span backward 3.20 ± 1.07 3 ± 0.76 ns
Trail making oral; time (sec.) 37.33 ± 6.33 34.65 ± 3.98 ns
Trail making oral; mistakes 7.98 ± 3.4 4.10 ± 0.40 P<0.01
Freezing of thoughts 1 ± 0.0 0.0
Freezing of language 1 ± 0.0 0.0
CIR 3.23 ± 0.43 0.98 ± 0.12 P<0.01
Proverbs’ Interpretation (correct answers) 4.76 ± 2.65 14.23 ± 2.45 P<0.01
Raven; time (min.) 35.53 ± 4.30 34.12 ± 7.20 ns
Raven; (correct answers) 21.34 ± 4.24 21.5 ± 4.04 ns
Stroop; time (sec.) 57.91 ± 39.56 22.38 ± 10.53 P<0.01
Stroop; mistakes 5 ± 4.23 1.23 ± 2.25 P<0.01
Retrieval of a story; (correct answers) 9.38 ± 5.60 10.13 ± 4.64 ns
Ten-Point Clock Test 1.88 ± 1.25 3.5 ± 0.53 P<0.01
Cornell’s Scale 7.75 ± 2.76 12.5 ± 3.59 P<0.01
Anxiety score 3.2 ± 1.71 2.93 ± 2.78 ns
Table 4: A comparison between the two groups, at 12 months.
Items Group A Over baseline Group B Over baseline P Av e r s u sB
Phonological ﬂuency −1.23 ± 0.20 ns +2.70 ± 0.40 ns P<0.01
Intrusion mistakes +3.45 ± 0.34 P<0.05 +0.23 ± 0.20 ns P<0.01
Digit span forward −0.40 ± 0.10 ns −0.50 ± 0.10 ns P<0.05
Digit span backward −1.10 ± 0.20 P<0.05 −1.23 ± 0.10 P<0.05 ns
Trail making oral; time (sec.) +3.20 ± 1.10 ns +3.10 ± 1. 80 ns ns
Trail making oral; mistakes +1.80 ± 0.20 P<0.05 +0.70 ± 0.20 ns P<0.01
Freezing of thoughts 1 ± 0.0 0.0
Freezing of language 1 ± 0.0 0.0
CIR +0.70 ± 0.91 ns +0.69 ± 0.39 ns P<0.01
Proverbs’ Interpretation (correct answers) −1.30 ± 0.50 P<0.05 +2.30 ± 0.50 P<0.05 P<0.01
Raven; time (min.) +1.50 ± 0.30 ns +1.70 ± 0.30 ns ns
Raven (correct answers) +1.40 ± 0.24 ns −0.50 ± 0.04 ns ns
Stroop; time (sec.) +7.20 ± 0.50 P<0.05 +2.90 ± 4.20 ns P<0.01
Stroop; mistakes +2.10 ± 0.40 P<0.05 +1.70 ± 0.90 ns P<0.01
R e t r i e v a lo fas t o r y( c o r r e c ta n s w e r s ) + 1 . 3 0± 0.20 ns −0.98 ± 0.60 ns ns
Ten-Point Clock Test −0.20 ± 0.50 ns +0.40 ± 0.20 ns P<0.01
Cornell’s Scale +1.20 ± 0.60 ns +4.50 ± 0.90 P<0.01 P<0.01
Anxiety score +0.10 ± 0.21 ns +1.20 ± 0.12 P<0.05 P<0.05
Parkinson’s disease in the elaboration of automatic move-
ment in conjunction with the supplementary motor area.
It has been suggested (see data and Literature in [40]) that
the basal ganglia maintains cortically selected motor set, in
the supplementary motor area, and provides internal cues to
the supplementary motor area, in order to enable each sub-
movement, to be correctly linked together [41]. Iansek et al.
[39]examinedthesequenceeﬀectinFOGsubjectsandfound
that, contrary to hypokinesia, the sequence eﬀect did not
respond to medication or attention strategies. It did disap-
pear with the use of external cues in that study; however,
no evidence was provided to support the hypothesis that
FOG was due to the presence of the sequence eﬀect (grad-
ual step to step reduction) in combination with an overall
reduced step length.
FOG leads to diﬃculties in set shifting [42] while
other executive domains, such as working memory, verbal
ﬂuency, and planning/organization abilities have weakerParkinson’s Disease 5
associations [43–47]. Thus, it would appear that the neural
network underlying FOG in PD may overlap with the net-
work controlling processes of set shifting [47].
The results obtained in our work can be summarized as
follows: two homogenous groups of patients, with Parkin-
son’s disease, followed for three years by a dedicated neu-
rologist, have been compared. There is overall PD duration
of 3-4 years since diagnosis. Patients have been tested in
on-pharmacological state; in this condition, only Group A
manifested on-freezing, Group B did not evidence it. Ef-
fectively, Group A (and therefore the matched cases selected
for Group B) had high UPDRS and H and Y scores and
L-Dopa equivalent dose over 1000mg/day, clear hallmarks
of advanced stage PD, which does not usually correspond
to 3-4 year PD duration. It was not our intention to select
a subgroup of patients with a worse form of PD, but in
fact, that it is the result: it seems that on-freezing and oﬀ-
precocious phenomena [46] are selected forms of an intrigu-
ing and rather complicated form of PD; the former case is
not sensitive to dopamine adjustment; the latter has good
response to therapy modulation, almost in precocious time.
Our study demonstrated that the cognitive and behav-
ioral proﬁle of these patients vary from those of patients
withParkinson’sdisease,whodidnotsuﬀerfromon-freezing
of gait. The results indicated that patients with Parkinson’s
disease and who did present freezing of gait could not focus
their attention on a given task, as indicated by the worse
scores obtained in the digit span forward task and in the
Trail Making test. They could not implement a correct verbal
logical judgment (as showed by the low score obtained
in the Proverbs’ Interpretation task). They showed worse
performances in executive function (as demonstrated by the
Stroop test and by the Ten-Point Clock test). Contradic-
torily, our patients with on-freezing produced much more
words in the phonological task than patients who suﬀered
from Parkinson’s disease without freezing. When examined
more closely, their verbal production contained a higher
percentage of intrusion words (semantically related to the
produced words, most of the time) than that of Parkinson’s
patients without freezing. Patients with oﬀ-freezing are more
depressed and with major introspection and insight than
patients with on-freezing.
Our results indicate that “induced” verbal ﬂuency is
qualitatively compromised in on-freezing patients with
Parkinson’s disease. Moreover, these patients altered the
focusing mechanism of selective attention, of the abstract
reasoning, judgment, and of the executive function, as well
as they showed a lack of insight in their clinical situation. In
our study, we observed that while the patients with the on-
freezing phenomenon manifest sudden brisk interruption
of thought or of speech, a simple provoked noise (even a
question formulated by the investigator) shortens the time
of them and accelerates the “rescue” of the cognitive process.
These considerations support what has been said about
motorblocksinPD.Thenovelexternalstimulus,represented
by the noise or by the examiner’s voice, seems to “oblige”
the cortex to process the novel stimulus. The consequential
results are the prosecution of the task.
Anatomical localization of the processes underlying
attentive control, utilizing functional magnetic resonance
imaginginPDpatients,hasidentiﬁedthatattentivecontrolis
related to increased activation of the ventrolateral prefrontal
cortex [48]. In addition, works in healthy controls have
proposed that the reward feedback mechanisms involved in
switching attention relate to regions within the orbitofrontal
cortex [49]. On-freezing (motor aspects, of course) has
been reported to improve with the applications of exter-
nal rhythmic stimuli, including metronome stimulation or
application of weak electromagnetic ﬁelds [50]. Thereby, the
use of external attentive strategies may allow movement to
be mediated by less automatic and more conscious attentive
motorcontrolprocesses(frontalcorticalregions),whichmay
be less impaired than the automatic process (subcortical
basal-ganglia-frontalneuralpathway)([39,51,52]).Chronic
on-line control exerted by the subcortical circuits might be
disruptedinon-freezingofgaitpatients,withanalterationof
a presumed “salient map” representation as a consequence.
Attention should be elicited with novel external stimuli,
in order to implement the cortical parietal circuits: when
the cortex actively participates, the patient can reapproach
the task and the stop is abolished [53–55]. We hypothesize
that the control exerted by the frontal-caudate-pulvinar
circuits might be disrupted in on-freezing; this circuit is
mainly involved in verifying the semantic acceptability of the
linguistic production and in the so-called language planning
loop [56, 57]. This hypothesis might explain the intrinsic
diﬃculty showed by on-FOG patients to suppress their
“intrusive verbal thoughts” in phonological tasks [58].
To speculate, one might say that on-freezing is not at all a
motor variance of Parkinson’s disease, but rather a complex,
wide-extended, syndrome, that involves gait (as one of the
most evident aspects), as well as cognition and behavior.
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